25 XP   0   0   10

Vistin Pharma ASA
Buy, Hold or Sell?

Let's analyse Vistin together

PenkeI guess you are interested in Vistin Pharma ASA. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Vistin Pharma ASA. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Vistin Pharma ASA

I send you an email if I find something interesting about Vistin Pharma ASA.

Quick analysis of Vistin (30 sec.)










What can you expect buying and holding a share of Vistin? (30 sec.)

How much money do you get?

How much money do you get?
kr0.00
When do you have the money?
1 year
How often do you get paid?
85.7%

What is your share worth?

Current worth
kr6.16
Expected worth in 1 year
kr5.93
How sure are you?
57.1%

+ What do you gain per year?

Total Gains per Share
kr-0.24
Return On Investment
-1.0%

For what price can you sell your share?

Current Price per Share
kr24.30
Expected price per share
kr23.50 - kr24.50
How sure are you?
50%

1. Valuation of Vistin (5 min.)




Live pricePrice per Share (EOD)

kr24.30

Intrinsic Value Per Share

kr-37.09 - kr-22.90

Total Value Per Share

kr-30.93 - kr-16.74

2. Growth of Vistin (5 min.)




Is Vistin growing?

Current yearPrevious yearGrowGrow %
How rich?$24.8m$25.1m-$238.7k-1.0%

How much money is Vistin making?

Current yearPrevious yearGrowGrow %
Making money-$429.1k$2.2m-$2.7m-629.2%
Net Profit Margin-1.6%9.0%--

How much money comes from the company's main activities?

3. Financial Health of Vistin (5 min.)




What can you expect buying and holding a share of Vistin? (5 min.)

Welcome investor! Vistin's management wants to use your money to grow the business. In return you get a share of Vistin.

What can you expect buying and holding a share of Vistin?

First you should know what it really means to hold a share of Vistin. And how you can make/lose money.

Speculation

The Price per Share of Vistin is kr24.30. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Vistin.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Vistin, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr6.16. Based on the TTM, the Book Value Change Per Share is kr-0.06 per quarter. Based on the YOY, the Book Value Change Per Share is kr0.08 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Vistin.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps-0.010.0%-0.010.0%0.050.2%-0.03-0.1%0.000.0%
Usd Book Value Change Per Share-0.010.0%-0.010.0%0.010.0%0.060.2%0.080.3%
Usd Dividend Per Share0.000.0%0.000.0%0.050.2%0.060.3%0.050.2%
Usd Total Gains Per Share-0.010.0%-0.010.0%0.050.2%0.120.5%0.130.6%
Usd Price Per Share1.44-1.44-1.76-1.28-1.39-
Price to Earnings Ratio-149.49--149.49-34.56--24.09--5.41-
Price-to-Total Gains Ratio-267.01--267.01-33.50--47.21--34.52-
Price to Book Ratio2.56-2.56-3.12-2.12-2.88-
Price-to-Total Gains Ratio-267.01--267.01-33.50--47.21--34.52-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.2113
Number of shares452
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.06
Usd Book Value Change Per Share-0.010.06
Usd Total Gains Per Share-0.010.12
Gains per Quarter (452 shares)-2.4355.58
Gains per Year (452 shares)-9.74222.33
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-10-20115107212
20-19-30230214434
30-29-40346321656
40-39-50461429878
50-49-605765361100
60-58-706916431322
70-68-808067501544
80-78-909218571766
90-88-10010379641988
100-97-110115210722210

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%4.03.00.057.1%4.03.00.057.1%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%4.03.00.057.1%4.03.00.057.1%
Dividend per Share0.00.01.00.0%2.00.01.066.7%4.00.01.080.0%6.00.01.085.7%6.00.01.085.7%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%4.03.00.057.1%4.03.00.057.1%

Fundamentals of Vistin

About Vistin Pharma ASA

Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. The company was founded in 1969 and is headquartered in Oslo, Norway.

Fundamental data was last updated by Penke on 2024-04-21 13:22:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Vistin Pharma ASA.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Vistin earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Vistin to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -1.6% means that kr-0.02 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Vistin Pharma ASA:

  • The MRQ is -1.6%. The company is making a loss. -1
  • The TTM is -1.6%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-1.6%TTM-1.6%0.0%
TTM-1.6%YOY9.0%-10.6%
TTM-1.6%5Y-7.8%+6.1%
5Y-7.8%10Y1.2%-9.0%
1.1.2. Return on Assets

Shows how efficient Vistin is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Vistin to the Drug Manufacturers - Specialty & Generic industry mean.
  • -1.2% Return on Assets means that Vistin generated kr-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Vistin Pharma ASA:

  • The MRQ is -1.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -1.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.2%TTM-1.2%0.0%
TTM-1.2%YOY7.5%-8.6%
TTM-1.2%5Y-5.1%+3.9%
5Y-5.1%10Y1.4%-6.5%
1.1.3. Return on Equity

Shows how efficient Vistin is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Vistin to the Drug Manufacturers - Specialty & Generic industry mean.
  • -1.7% Return on Equity means Vistin generated kr-0.02 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Vistin Pharma ASA:

  • The MRQ is -1.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -1.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.7%TTM-1.7%0.0%
TTM-1.7%YOY9.0%-10.8%
TTM-1.7%5Y-6.7%+4.9%
5Y-6.7%10Y4.6%-11.3%

1.2. Operating Efficiency of Vistin Pharma ASA.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Vistin is operating .

  • Measures how much profit Vistin makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Vistin to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -2.1% means the company generated kr-0.02  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Vistin Pharma ASA:

  • The MRQ is -2.1%. The company is operating very inefficient. -2
  • The TTM is -2.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-2.1%TTM-2.1%0.0%
TTM-2.1%YOY11.9%-14.1%
TTM-2.1%5Y6.6%-8.7%
5Y6.6%10Y6.7%-0.2%
1.2.2. Operating Ratio

Measures how efficient Vistin is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.72 means that the operating costs are kr1.72 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Vistin Pharma ASA:

  • The MRQ is 1.716. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.716. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.716TTM1.7160.000
TTM1.716YOY1.215+0.501
TTM1.7165Y1.443+0.273
5Y1.44310Y1.608-0.165

1.3. Liquidity of Vistin Pharma ASA.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Vistin is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.38 means the company has kr1.38 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Vistin Pharma ASA:

  • The MRQ is 1.380. The company is just able to pay all its short-term debts.
  • The TTM is 1.380. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.380TTM1.3800.000
TTM1.380YOY3.359-1.979
TTM1.3805Y3.484-2.104
5Y3.48410Y3.125+0.359
1.3.2. Quick Ratio

Measures if Vistin is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Vistin to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.59 means the company can pay off kr0.59 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Vistin Pharma ASA:

  • The MRQ is 0.592. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.592. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.592TTM0.5920.000
TTM0.592YOY1.852-1.259
TTM0.5925Y2.687-2.095
5Y2.68710Y2.322+0.365

1.4. Solvency of Vistin Pharma ASA.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Vistin assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Vistin to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.33 means that Vistin assets are financed with 32.9% credit (debt) and the remaining percentage (100% - 32.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Vistin Pharma ASA:

  • The MRQ is 0.329. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.329. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.329TTM0.3290.000
TTM0.329YOY0.172+0.157
TTM0.3295Y0.227+0.102
5Y0.22710Y0.279-0.051
1.4.2. Debt to Equity Ratio

Measures if Vistin is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Vistin to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 49.0% means that company has kr0.49 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Vistin Pharma ASA:

  • The MRQ is 0.490. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.490. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.490TTM0.4900.000
TTM0.490YOY0.208+0.283
TTM0.4905Y0.307+0.184
5Y0.30710Y0.423-0.116

2. Market Valuation of Vistin Pharma ASA

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Vistin generates.

  • Above 15 is considered overpriced but always compare Vistin to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -149.49 means the investor is paying kr-149.49 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Vistin Pharma ASA:

  • The EOD is -229.907. Based on the earnings, the company is expensive. -2
  • The MRQ is -149.487. Based on the earnings, the company is expensive. -2
  • The TTM is -149.487. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-229.907MRQ-149.487-80.420
MRQ-149.487TTM-149.4870.000
TTM-149.487YOY34.560-184.047
TTM-149.4875Y-24.087-125.400
5Y-24.08710Y-5.406-18.681
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Vistin Pharma ASA:

  • The EOD is -14.406. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -9.367. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -9.367. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-14.406MRQ-9.367-5.039
MRQ-9.367TTM-9.3670.000
TTM-9.367YOY-47.067+37.700
TTM-9.3675Y145.814-155.181
5Y145.81410Y104.983+40.831
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Vistin is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Vistin Pharma ASA:

  • The EOD is 3.943. Based on the equity, the company is fair priced.
  • The MRQ is 2.564. Based on the equity, the company is underpriced. +1
  • The TTM is 2.564. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD3.943MRQ2.564+1.379
MRQ2.564TTM2.5640.000
TTM2.564YOY3.115-0.551
TTM2.5645Y2.117+0.447
5Y2.11710Y2.876-0.759
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Vistin Pharma ASA compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.059-0.0590%0.079-175%0.651-109%0.880-107%
Book Value Per Share--6.1626.1620%6.221-1%7.143-14%6.162+0%
Current Ratio--1.3801.3800%3.359-59%3.484-60%3.125-56%
Debt To Asset Ratio--0.3290.3290%0.172+91%0.227+45%0.279+18%
Debt To Equity Ratio--0.4900.4900%0.208+136%0.307+60%0.423+16%
Dividend Per Share----0%0.500-100%0.700-100%0.594-100%
Eps---0.106-0.1060%0.561-119%-0.380+259%0.017-737%
Free Cash Flow Per Share---1.687-1.6870%-0.412-76%-1.573-7%-1.084-36%
Free Cash Flow To Equity Per Share---0.811-0.8110%-0.937+16%-0.374-54%-0.734-9%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---22.901--------
Intrinsic Value_10Y_min---37.093--------
Intrinsic Value_1Y_max---1.733--------
Intrinsic Value_1Y_min---2.604--------
Intrinsic Value_3Y_max---5.635--------
Intrinsic Value_3Y_min---8.835--------
Intrinsic Value_5Y_max---10.053--------
Intrinsic Value_5Y_min---16.125--------
Market Cap1004873040.000+30%700644553.600700644553.6000%859398192.960-18%625170058.016+12%659880866.080+6%
Net Profit Margin---0.016-0.0160%0.090-118%-0.078+374%0.012-234%
Operating Margin---0.021-0.0210%0.119-118%0.066-132%0.067-131%
Operating Ratio--1.7161.7160%1.215+41%1.443+19%1.608+7%
Pb Ratio3.943+35%2.5642.5640%3.115-18%2.117+21%2.876-11%
Pe Ratio-229.907-54%-149.487-149.4870%34.560-533%-24.087-84%-5.406-96%
Price Per Share24.300+35%15.80015.8000%19.380-18%14.098+12%15.229+4%
Price To Free Cash Flow Ratio-14.406-54%-9.367-9.3670%-47.067+402%145.814-106%104.983-109%
Price To Total Gains Ratio-410.661-54%-267.014-267.0140%33.498-897%-47.207-82%-34.524-87%
Quick Ratio--0.5920.5920%1.852-68%2.687-78%2.322-74%
Return On Assets---0.012-0.0120%0.075-115%-0.051+338%0.014-184%
Return On Equity---0.017-0.0170%0.090-119%-0.067+287%0.046-138%
Total Gains Per Share---0.059-0.0590%0.579-110%1.351-104%1.475-104%
Usd Book Value--24866933.00024866933.0000%25105717.000-1%28825214.600-14%24577423.000+1%
Usd Book Value Change Per Share---0.005-0.0050%0.007-175%0.059-109%0.080-107%
Usd Book Value Per Share--0.5610.5610%0.566-1%0.650-14%0.561+0%
Usd Dividend Per Share----0%0.046-100%0.064-100%0.054-100%
Usd Eps---0.010-0.0100%0.051-119%-0.035+259%0.002-737%
Usd Free Cash Flow---6806800.000-6806800.0000%-1661569.000-76%-6349379.400-7%-4385511.000-36%
Usd Free Cash Flow Per Share---0.153-0.1530%-0.037-76%-0.143-7%-0.099-36%
Usd Free Cash Flow To Equity Per Share---0.074-0.0740%-0.085+16%-0.034-54%-0.067-9%
Usd Market Cap91443446.640+30%63758654.37863758654.3780%78205235.559-18%56890475.279+12%60049158.813+6%
Usd Price Per Share2.211+35%1.4381.4380%1.764-18%1.283+12%1.386+4%
Usd Profit---429156.000-429156.0000%2270905.000-119%-1531348.000+257%-10660.000-98%
Usd Revenue--26178425.00026178425.0000%25354693.000+3%22670520.600+15%20706881.000+26%
Usd Total Gains Per Share---0.005-0.0050%0.053-110%0.123-104%0.134-104%
 EOD+5 -3MRQTTM+0 -0YOY+6 -295Y+12 -2310Y+10 -25

3.2. Fundamental Score

Let's check the fundamental score of Vistin Pharma ASA based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-229.907
Price to Book Ratio (EOD)Between0-13.943
Net Profit Margin (MRQ)Greater than0-0.016
Operating Margin (MRQ)Greater than0-0.021
Quick Ratio (MRQ)Greater than10.592
Current Ratio (MRQ)Greater than11.380
Debt to Asset Ratio (MRQ)Less than10.329
Debt to Equity Ratio (MRQ)Less than10.490
Return on Equity (MRQ)Greater than0.15-0.017
Return on Assets (MRQ)Greater than0.05-0.012
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Vistin Pharma ASA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5061.578
Ma 20Greater thanMa 5023.305
Ma 50Greater thanMa 10023.094
Ma 100Greater thanMa 20022.798
OpenGreater thanClose23.500
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in NOK. All numbers in thousands.

Summary
Total Assets407,213
Total Liabilities133,950
Total Stockholder Equity273,263
 As reported
Total Liabilities 133,950
Total Stockholder Equity+ 273,263
Total Assets = 407,213

Assets

Total Assets407,213
Total Current Assets154,113
Long-term Assets248,031
Total Current Assets
Cash And Cash Equivalents 1,435
Net Receivables 66,155
Inventory 83,446
Total Current Assets  (as reported)154,113
Total Current Assets  (calculated)151,036
+/- 3,077
Long-term Assets
Property Plant Equipment 219,430
Other Assets 28,535
Long-term Assets  (as reported)248,031
Long-term Assets  (calculated)247,965
+/- 66

Liabilities & Shareholders' Equity

Total Current Liabilities111,671
Long-term Liabilities16,155
Total Stockholder Equity273,263
Total Current Liabilities
Short Long Term Debt 45,141
Accounts payable 41,428
Other Current Liabilities 24,978
Total Current Liabilities  (as reported)111,671
Total Current Liabilities  (calculated)111,547
+/- 124
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt2,956
Other Liabilities 13,200
Long-term Liabilities  (as reported)16,155
Long-term Liabilities  (calculated)16,156
+/- 1
Total Stockholder Equity
Common Stock44,345
Retained Earnings 22,140
Total Stockholder Equity (as reported)273,263
Total Stockholder Equity (calculated)66,485
+/- 206,778
Other
Capital Stock44,345
Common Stock Shares Outstanding 44,345
Net Debt 43,706
Net Invested Capital 318,404
Net Tangible Assets 273,370
Net Working Capital 41,387
Property Plant and Equipment Gross 272,902



Balance Sheet

Currency in NOK. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
> Total Assets 
279,517
231,749
500,062
504,165
321,915
333,147
407,213
407,213333,147321,915504,165500,062231,749279,517
   > Total Current Assets 
225,965
160,063
389,293
394,629
141,526
137,831
154,113
154,113137,831141,526394,629389,293160,063225,965
       Cash And Cash Equivalents 
79,940
69,383
320,733
319,672
77,036
35,746
1,435
1,43535,74677,036319,672320,73369,38379,940
       Net Receivables 
49,858
36,122
31,566
48,931
30,400
40,245
66,155
66,15540,24530,40048,93131,56636,12249,858
       Inventory 
79,316
22,655
29,071
24,107
31,788
42,907
83,446
83,44642,90731,78824,10729,07122,65579,316
   > Long-term Assets 
53,552
71,686
88,550
109,535
180,389
195,316
248,031
248,031195,316180,389109,53588,55071,68653,552
       Property Plant Equipment 
53,552
71,686
88,550
101,802
145,261
167,457
219,430
219,430167,457145,261101,80288,55071,68653,552
       Other Assets 
0
0
22,219
7,734
35,128
27,859
28,535
28,53527,85935,1287,73422,21900
> Total Liabilities 
92,906
111,592
151,210
90,769
49,510
57,260
133,950
133,95057,26049,51090,769151,210111,59292,906
   > Total Current Liabilities 
80,617
96,854
134,333
73,238
32,204
41,035
111,671
111,67141,03532,20473,238134,33396,85480,617
       Short Long Term Debt 
0
0
0
0
0
0
45,141
45,141000000
       Accounts payable 
37,459
48,790
29,469
23,612
17,893
20,808
41,428
41,42820,80817,89323,61229,46948,79037,459
       Other Current Liabilities 
9,292
14,456
89,580
38,082
2,622
2,775
24,978
24,9782,7752,62238,08289,58014,4569,292
   > Long-term Liabilities 
12,289
14,738
16,877
17,531
17,306
16,344
16,155
16,15516,34417,30617,53116,87714,73812,289
       Long term Debt Total 
0
0
0
1,298
0
0
0
0001,298000
       Other Liabilities 
12,289
14,738
16,877
16,309
17,306
15,832
13,200
13,20015,83217,30616,30916,87714,73812,289
> Total Stockholder Equity
186,611
120,157
348,852
413,396
272,405
275,887
273,263
273,263275,887272,405413,396348,852120,157186,611
   Common Stock
17,055
17,055
44,345
44,345
44,345
44,345
44,345
44,34544,34544,34544,34544,34517,05517,055
   Retained Earnings 
32,042
102,028
28,329
95,649
-996
24,538
22,140
22,14024,538-99695,64928,329102,02832,042
   Capital Surplus 
137,514
1,074
276,178
273,401
229,056
206,885
0
0206,885229,056273,401276,1781,074137,514
   Treasury Stock0000000
   Other Stockholders Equity 
0
0
2,777
1
0
0
0
00012,77700



Balance Sheet

Currency in NOK. All numbers in thousands.




Cash Flow

Currency in NOK. All numbers in thousands.




Income Statement

Currency in NOK. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue287,675
Cost of Revenue-199,876
Gross Profit166,79987,799
 
Operating Income (+$)
Gross Profit166,799
Operating Expense-293,771
Operating Income-6,096-126,972
 
Operating Expense (+$)
Research Development0
Selling General Administrative19,820
Selling And Marketing Expenses0
Operating Expense293,77119,820
 
Net Interest Income (+$)
Interest Income28
Interest Expense-2,140
Other Finance Cost-312
Net Interest Income-2,424
 
Pretax Income (+$)
Operating Income-6,096
Net Interest Income-2,424
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-6,008-6,096
EBIT - interestExpense = -8,236
-6,038
-2,576
Interest Expense2,140
Earnings Before Interest and Taxes (EBIT)-6,096-3,868
Earnings Before Interest and Taxes (EBITDA)8,412
 
After tax Income (+$)
Income Before Tax-6,008
Tax Provision--1,293
Net Income From Continuing Ops-4,715-4,715
Net Income-4,716
Net Income Applicable To Common Shares-4,687
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses81,632
Total Other Income/Expenses Net02,424
 

Technical Analysis of Vistin
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Vistin. The general trend of Vistin is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Vistin's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Vistin Pharma ASA.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 24.50 < 24.50.

The bearish price targets are: 24.20 > 24.20 > 23.50.

Tweet this
Vistin Pharma ASA Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Vistin Pharma ASA. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Vistin Pharma ASA Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Vistin Pharma ASA. The current macd is 0.3575709.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Vistin price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Vistin. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Vistin price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Vistin Pharma ASA Daily Moving Average Convergence/Divergence (MACD) ChartVistin Pharma ASA Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Vistin Pharma ASA. The current adx is 17.32.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Vistin shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Vistin Pharma ASA Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Vistin Pharma ASA. The current sar is 22.85.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Vistin Pharma ASA Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Vistin Pharma ASA. The current rsi is 61.58. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Vistin Pharma ASA Daily Relative Strength Index (RSI) ChartVistin Pharma ASA Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Vistin Pharma ASA. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Vistin price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Vistin Pharma ASA Daily Stochastic Oscillator ChartVistin Pharma ASA Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Vistin Pharma ASA. The current cci is 120.19.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Vistin Pharma ASA Daily Commodity Channel Index (CCI) ChartVistin Pharma ASA Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Vistin Pharma ASA. The current cmo is 30.24.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Vistin Pharma ASA Daily Chande Momentum Oscillator (CMO) ChartVistin Pharma ASA Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Vistin Pharma ASA. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Vistin Pharma ASA Daily Williams %R ChartVistin Pharma ASA Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Vistin Pharma ASA.

Vistin Pharma ASA Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Vistin Pharma ASA. The current atr is 0.72862253.

Vistin Pharma ASA Daily Average True Range (ATR) ChartVistin Pharma ASA Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Vistin Pharma ASA. The current obv is 289,417.

Vistin Pharma ASA Daily On-Balance Volume (OBV) ChartVistin Pharma ASA Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Vistin Pharma ASA. The current mfi is 92.41.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Vistin Pharma ASA Daily Money Flow Index (MFI) ChartVistin Pharma ASA Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Vistin Pharma ASA.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-01CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-14CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-10CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-23CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-26MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23CCI LONG ENTRY SHORT CLOSE100 crossover to upside

6.3. Candlestick Patterns

Vistin Pharma ASA Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Vistin Pharma ASA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5061.578
Ma 20Greater thanMa 5023.305
Ma 50Greater thanMa 10023.094
Ma 100Greater thanMa 20022.798
OpenGreater thanClose23.500
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Vistin with someone you think should read this too:
  • Are you bullish or bearish on Vistin? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Vistin? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Vistin Pharma ASA

I send you an email if I find something interesting about Vistin Pharma ASA.


Comments

How you think about this?

Leave a comment

Stay informed about Vistin Pharma ASA.

Receive notifications about Vistin Pharma ASA in your mailbox!